Prot# MA 19547:Randomized, Open-Label, Multi-Center Study to Investigate Patient Preference on Dosing in Women w/Postmenopausal Osteoporosis Treated w/Once-Monthly Ibandronate & Once-Weekly Risedronate. A 6-Month, 2-Sequence, & 2-Period Crossov

Project: Research project

Project Details

StatusFinished
Effective start/end date12/18/06 → 3/18/07

Funding

  • Quintiles, Inc. (MA 19547)
  • Hoffman-La Roche, Inc. (MA 19547)